Belgian Retail REITs Stock News

As European markets navigate the complexities of Middle East conflicts and energy price volatility, indices like the STOXX Europe 600 have shown modest gains, reflecting a cautious optimism amidst geopolitical uncertainties. In these fluctuating times, dividend stocks can offer investors a measure of stability and potential income, making them an appealing consideration for those looking to balance risk with consistent returns.

Syensqo share performance snapshot Syensqo (ENXTBR:SYENS) has attracted attention after a recent move that left the stock about 2% higher over the past month, yet showing a roughly 28% decline over the past 3 months. Over the past year, Syensqo’s total return is about 20% lower, while year to date performance shows a similar decline of around 29%. These moves provide context for assessing its current valuation. See our latest analysis for Syensqo. Syensqo’s share price, now at €49.48, has...

Syensqo has redeemed €500 million of senior bonds that were originally due in 2027. This move completes a wider debt refinancing step following the company’s recent spin off. The early redemption changes the company’s debt profile and may influence future interest costs. The bond redemption comes at a time when Syensqo (ENXTBR:SYENS) shares trade around €49.0. The stock has seen a 12.6% gain over the past week, while returns over the past month, year to date, and past year show declines of...

SCR-Sibelco N.V.'s ( EBR:094426466 ) healthy profit numbers didn't contain any surprises for investors. However the...

Sofina Société Anonyme (ENXTBR:SOF) opened FY 2025 with a weak first half, reporting a loss as basic EPS swung to €11.87 and total revenue came in at a loss of €358.9 million. This comes against a backdrop where the trailing twelve months still show positive EPS of €12.48 and revenue of €486.1 million. Over the past year, the company has seen total revenue move from €587.1 million in 2024 H1 to €844.98 million in 2024 H2 and EPS shift from €16.59 to €24.29 in the same periods, before the...

The European market has recently faced challenges, with the pan-European STOXX Europe 600 Index declining by 3.79% amid heightened geopolitical tensions and soaring energy costs, prompting caution from the European Central Bank regarding inflation risks. In this environment of uncertainty, high-growth tech stocks in Europe are gaining attention for their potential to offer resilience and innovation-driven growth, making them an intriguing focus for investors seeking opportunities in a...

Today is shaping up negative for Banqup Group SA ( EBR:BANQ ) shareholders, with the analysts delivering a substantial...

SCR-Sibelco (ENXTBR:094426466) has put fresh numbers on the table for FY 2025, reporting first half revenue of €1.2b and net income of €78.1m, while trailing 12 month revenue is €2.3b against net income of €63.4m. Over the past year, revenue has moved from €1.1b in the first half of 2024 and €1.1b in the second half of 2024 to €1.2b in the first half of 2025. Net income shifted from €145.9m to a loss of €14.7m and then to €78.1m over the same periods. For investors, the key storyline is how...

Nyxoah (ENXTBR:NYXH) just wrapped up FY 2025 with Q4 revenue of €5.6 million and a basic EPS loss of €0.586, alongside trailing twelve month revenue of €10.0 million and a basic EPS loss of €2.364 on net income losses of €90.1 million. Over recent quarters the company has seen revenue move from €1.3 million in Q4 2024 to €5.6 million in Q4 2025, while quarterly basic EPS losses widened from €0.463 to €0.586 and trailing twelve month net income losses went from €59.2 million to €90.1 million...

argenx (ENXTBR:ARGX) is back in focus after strong fourth quarter results and detailed analyst commentary around Vyvgart, with attention now shifting to the product’s revenue mix and upcoming clinical catalysts. See our latest analysis for argenx. Despite strong Q4 Vyvgart revenues and upcoming data presentations at the AAN meeting drawing attention to the pipeline, argenx’s recent 30 day share price return of 14.04% decline and year to date share price return of 17.13% decline contrast with...

What Elia Group’s latest earnings mean for shareholders Elia Group (ENXTBR:ELI) released full year 2025 results on 5 March, reporting sales of €4,442.2m and net income of €585.9m, figures that helped shape recent sentiment around the stock. See our latest analysis for Elia Group. Elia Group’s recent earnings update has arrived alongside firm share price momentum, with a 28.6% 90 day share price return and a 70.54% 1 year total shareholder return indicating that optimism has been building...

D'Ieteren Group (ENXTBR:DIE) has just posted its FY 2025 numbers with first half revenue of about €4.1b and basic EPS of €4.61, backed by trailing 12 month EPS of €8.40 that lines up with reported earnings growth of 17.3% over the past year. The company has seen revenue move from about €4.3b in the first half of 2024 and €3.9b in the second half of 2024 to €4.1b in the first half of 2025. Trailing 12 month net income, excluding extra items, sits at €445m, alongside earnings growth of roughly...

Proximus (ENXTBR:PROX) has just released its full year 2025 results, reporting €6,248 million in sales, €6,620 million in revenue, and net income of €398 million, with earnings per share of €1.23. See our latest analysis for Proximus. At a share price of €7.29, Proximus has had a mixed run, with a 9.05% decline in its 1 month share price return and a 4.29% gain over 3 months. Its 1 year total shareholder return of 16.63% contrasts with a 39.98% total shareholder return decline over five...

Cmb.Tech (ENXTBR:CMBT) has drawn investor attention after reporting full year 2025 results, declaring an interim dividend of US$0.16 per share and announcing a Management Board change involving Chief Strategy Officer Benoit Timmermans. See our latest analysis for Cmb.Tech. The share price has pulled back over the past week with a 7 day share price return of a 6.27% decline. However, the 90 day share price return of 37.34% and 1 year total shareholder return of 43.99% point to momentum that...

Syensqo SA has recently reported weaker fourth-quarter and full-year 2025 results, announced an annual dividend of €1.1340 per share for payment on 18 May 2026, redeemed €500,000,000 of 2.750% fixed-rate bonds early, and confirmed several Board changes including appointing Heike van de Kerkhof as independent Chair. These moves combine pressure on profitability with balance sheet reshaping and refreshed governance, giving investors a complex mix of cost, capital allocation and oversight...

Shurgard Self Storage (ENXTBR:SHUR) caught investor attention after releasing its 2025 results, reporting revenue of €450.85 million and net income of €597.76 million, along with fresh 2026 guidance for 6% to 8% all store revenue growth. See our latest analysis for Shurgard Self Storage. The latest guidance and 2025 results came after a weak patch for the shares, with a 30-day share price return showing a 10.62% decline and a 1-year total shareholder return showing a 9.73% decline. The recent...

Argenx (ENXTBR:ARGX) reported positive topline Phase 3 ADAPT OCULUS results for VYVGART in adults with ocular myasthenia gravis. The study met its primary endpoint with statistically significant efficacy in this patient group, which currently has limited treatment options. The data are intended to support regulatory submissions that could extend the existing VYVGART label to include ocular myasthenia gravis. Argenx is pairing these results with a broader push to expand VYVGART indications...

UCB (ENXTBR:UCB) has kicked off FY 2025 with first half revenue of €3.5b and basic EPS of €2.50, following a FY 2024 second half that delivered €3.4b in revenue and basic EPS of €4.51. The company has reported an increase in revenue from €2.8b and basic EPS of €1.10 in the first half of 2024 to the latest €3.5b and €2.50, with trailing 12 month basic EPS of €8.20 on revenue of €7.7b. For investors, that mix of higher recent earnings, stronger trailing profitability and a 20.1% net margin...

Earnings and dividend announcement set the tone Gimv (ENXTBR:GIMB) has drawn fresh attention after reporting net income of €173.31 million for the nine months to December 31, 2025, and confirming an annual dividend of €1.3650 per share. See our latest analysis for Gimv. The earnings release and dividend confirmation appear to have fed into a positive trend, with Gimv’s 1-day share price return of 1.95% and 7-day share price return of 4.32% lifting the share price to €47.1. The 1-year total...

Wondering if Solvay at €27.88 is offering good value right now, or if the best days are already priced in? This article breaks down what the current share price might be telling you. Over the short term the stock has returned 0.9% in the last 7 days and 7.1% over the past month. The year to date return sits at 2.0% and the 1 year return shows a 4.0% decline, compared with a 3 year return of 50.0% and 5 year return of 63.7%. Recent attention around Solvay has largely focused on how investors...

If you are wondering whether SCR-Sibelco is priced fairly today, you are not alone. The stock often attracts attention from investors trying to work out if they might be overpaying or missing an opportunity. Over the short term, the share price has been mixed, with a 1.3% return over the last 7 days, a 0.8% decline over 30 days, and returns of 12.7% decline year to date and 5.7% decline over the past year, extending to a 10.9% decline over five years. Recent news coverage has mainly focused...

Key Insights Significant control over Biotalys by private equity firms implies that the general public has more power...

It's been a good week for Anheuser-Busch InBev SA/NV ( EBR:ABI ) shareholders, because the company has just released...

Shareholders might have noticed that KBC Group NV ( EBR:KBC ) filed its yearly result this time last week. The early...